×

UPSC Courses

upsc prelims pt pointers
Novavax

Novavax American company Novavax, whose COVID-19 vaccine is set to be made in large numbers by the Pune-based Serum Institute of India (SII), has reported that its vaccine has proved to have 89% efficacy in preventing the infection in some trial volunteers in the United Kingdom. However, the efficacy dropped to 60% when it was tested in volunteers in South Africa, a likely consequence of a mutant coronavirus variant that is now deep-rooted there. Since December, scientists have raised

Toppers
Post Feed

Search By Date

Newsletter Subscription
SMS Alerts

Important Links

UPSC GS Mains Crash Course - RAW Prelims Answer Key 2024